EV/EBITDA
13.39
-0.37-2.69%
Thu, 13 Mar 2025 23:24:39 GMT
Summary
- As of March 14, 2025, RPRX EV/EBITDA is 13.39, with a fall of -0.37 (-2.69%) during the most recent trading day.
- Over the past year, RPRX EV/EBITDA has increased by +3.16 (+30.89%).
- RPRX EV/EBITDA is now -75.42% below its all-time high of 54.48.
Performance
RPRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RPRX EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -2.7% | -2.7% | -3.9% |
1 m1 month | +0.4% | +0.4% | +0.6% |
3 m3 months | +44.6% | +17.2% | +30.5% |
6 m6 months | -10.8% | +14.2% | +17.9% |
ytdytd | +15.4% | +15.4% | +28.1% |
1 y1 year | +30.9% | +8.0% | +6.9% |
5 y5 years | - | - | - |
RPRX EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -2.7% | 13.23 | +1.2% | |
3 m | 3-month | 13.76 | -2.7% | 9.14 | +46.5% |
6 m | 6-month | 15.48 | -13.5% | 9.14 | +46.5% |
1 y | 1-year | 15.62 | -14.3% | 9.14 | +46.5% |
3 y | 3-year | 54.48 | -75.4% | 9.14 | +46.5% |
5 y | 5-year | 54.48 | -75.4% | 5.90 | +127.0% |
alltime | all time | 54.48 | -75.4% | 5.90 | +127.0% |
Royalty Pharma EV/EBITDA History
Date | Value |
---|---|
2025 | 13.39(+15.4%) |
2024 | 11.60(+20.5%) |
2023 | 9.63(-82.2%) |
Date | Value |
---|---|
2022 | 54.07(+239.0%) |
2021 | 15.95(+23.8%) |
2020 | 12.88 |
FAQ
- What is Royalty Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for Royalty Pharma?
- What is RPRX EV/EBITDA year-to-date change?
- What is Royalty Pharma EV/EBITDA year-on-year change?
What is Royalty Pharma EV/EBITDA?
The current EV/EBITDA of RPRX is 13.39
What is the all time high EV/EBITDA for Royalty Pharma?
Royalty Pharma all-time high EV/EBITDA is 54.48
What is RPRX EV/EBITDA year-to-date change?
Royalty Pharma EV/EBITDA has changed by +1.79 (+15.43%) since the beginning of the year
What is Royalty Pharma EV/EBITDA year-on-year change?
Over the past year, RPRX EV/EBITDA has changed by +3.16 (+30.89%)